Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Statement Regarding Argentex Group PLC

29 May 2025 07:00

RNS Number : 4904K
Argentex Group PLC
29 May 2025
 

29th May 2025

 

Statement Regarding Argentex Group PLC

No Intention to Make an Offer

 

Further to the announcement by Argentex Group PLC ("Argentex") on 23rd April 2025, Terry Clune and Harry Adams confirm that they do not intend to make an offer for Argentex.

This announcement is made in accordance with Rule 2.6(d). Accordingly, Terry Clune and Harry Adams, and any person(s) acting in concert with them, are bound by restrictions as set out in Rule 2.8 of the City Code on Takeovers and Mergers (the "Code").

Under Note 2 on Rule 2.8 of the Code, Terry Clune and Harry Adams, and any person(s) acting in concert with them, reserve the right to set the restrictions in Rule 2.8 of the Code aside in the following circumstances:

(a) with the agreement of the board of directors of Argentex provided that such agreement is only given if the recommended cash acquisition of Argentex by IFX (UK) Ltd ("IFX") is withdrawn or lapses, and only after such lapse or withdrawal;

(b) following the announcement of a firm intention to make an offer for Argentex by or on behalf of a third party other than IFX;

(c) following the announcement by Argentex of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

(d) where the Takeover Panel has determined that there has been a material change of circumstances.

This announcement is being made with the consent of Terry Clune and Harry Adams.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBLGDUGXDDGUI
Date   Source Headline
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 20204:00 pmRNSDirector/PDMR Shareholding
18th Mar 202011:46 amRNSDirector/PDMR Shareholding
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:41 pmRNSDirector/PDMR Shareholding
11th Mar 20204:41 pmRNSHolding(s) in Company
11th Mar 20204:41 pmRNSSecond Price Monitoring Extn
11th Mar 20204:35 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:37 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
26th Feb 202012:08 pmRNSSecond Price Monitoring Extn
26th Feb 202012:02 pmRNSPrice Monitoring Extension
24th Feb 20204:40 pmRNSSecond Price Monitoring Extn
24th Feb 20204:35 pmRNSPrice Monitoring Extension
20th Nov 20197:00 amRNSInterim Results Statement
7th Oct 20197:00 amRNSTrading Update
5th Aug 20197:00 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.